NO2788478T3 - - Google Patents
Info
- Publication number
- NO2788478T3 NO2788478T3 NO12798308A NO12798308A NO2788478T3 NO 2788478 T3 NO2788478 T3 NO 2788478T3 NO 12798308 A NO12798308 A NO 12798308A NO 12798308 A NO12798308 A NO 12798308A NO 2788478 T3 NO2788478 T3 NO 2788478T3
- Authority
- NO
- Norway
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
- G02B27/01—Head-up displays
- G02B27/017—Head mounted
- G02B27/0172—Head mounted characterised by optical features
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
- G02B27/0081—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00 with means for altering, e.g. enlarging, the entrance or exit pupil
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
- G02B27/42—Diffraction optics, i.e. systems including a diffractive element being designed for providing a diffractive effect
- G02B27/4272—Diffraction optics, i.e. systems including a diffractive element being designed for providing a diffractive effect having plural diffractive elements positioned sequentially along the optical path
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B5/00—Optical elements other than lenses
- G02B5/18—Diffraction gratings
- G02B5/1814—Diffraction gratings structurally combined with one or more further optical elements, e.g. lenses, mirrors, prisms or other diffraction gratings
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B6/00—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
- G02B6/0001—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings specially adapted for lighting devices or systems
- G02B6/0011—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings specially adapted for lighting devices or systems the light guides being planar or of plate-like form
- G02B6/0013—Means for improving the coupling-in of light from the light source into the light guide
- G02B6/0015—Means for improving the coupling-in of light from the light source into the light guide provided on the surface of the light guide or in the bulk of it
- G02B6/0016—Grooves, prisms, gratings, scattering particles or rough surfaces
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B6/00—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
- G02B6/0001—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings specially adapted for lighting devices or systems
- G02B6/0011—Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings specially adapted for lighting devices or systems the light guides being planar or of plate-like form
- G02B6/0033—Means for improving the coupling-out of light from the light guide
- G02B6/0035—Means for improving the coupling-out of light from the light guide provided on the surface of the light guide or in the bulk of it
- G02B6/0038—Linear indentations or grooves, e.g. arc-shaped grooves or meandering grooves, extending over the full length or width of the light guide
-
- G—PHYSICS
- G06—COMPUTING OR CALCULATING; COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T19/00—Manipulating 3D models or images for computer graphics
- G06T19/006—Mixed reality
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
- G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
- G02B27/01—Head-up displays
- G02B27/0101—Head-up displays characterised by optical features
- G02B2027/0123—Head-up displays characterised by optical features comprising devices increasing the field of view
- G02B2027/0125—Field-of-view increase by wavefront division
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
- G02B27/01—Head-up displays
- G02B27/017—Head mounted
- G02B27/0172—Head mounted characterised by optical features
- G02B2027/0174—Head mounted characterised by optical features holographic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Virology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rehabilitation Therapy (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Computer Hardware Design (AREA)
- Computer Graphics (AREA)
- General Engineering & Computer Science (AREA)
- Software Systems (AREA)
- Theoretical Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2011/072387 WO2012076715A1 (en) | 2010-12-09 | 2011-12-09 | Mgmt-based method for obtaining high yield of recombinant protein expression |
| US201261642924P | 2012-05-04 | 2012-05-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2788478T3 true NO2788478T3 (enExample) | 2018-01-20 |
Family
ID=49514226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO12798308A NO2788478T3 (enExample) | 2011-12-09 | 2012-12-10 |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US9638692B2 (enExample) |
| EP (2) | EP2788478B1 (enExample) |
| JP (2) | JP6215223B2 (enExample) |
| KR (2) | KR102007061B1 (enExample) |
| CN (2) | CN104114697A (enExample) |
| AU (2) | AU2012350229B2 (enExample) |
| BR (2) | BR112014013745B1 (enExample) |
| CA (2) | CA2857998C (enExample) |
| DK (1) | DK2788478T3 (enExample) |
| ES (1) | ES2648899T3 (enExample) |
| MX (2) | MX349562B (enExample) |
| NO (1) | NO2788478T3 (enExample) |
| NZ (1) | NZ701380A (enExample) |
| SG (2) | SG11201403010TA (enExample) |
| WO (2) | WO2013083847A2 (enExample) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103476928B (zh) * | 2010-12-09 | 2017-03-29 | 巴斯德研究所 | 用于获得高产量重组蛋白表达的基于mgmt的方法 |
| EP2788478B1 (en) | 2011-12-09 | 2017-08-23 | Institut Pasteur | Multiplex immuno screening assay |
| GB201210226D0 (en) * | 2012-06-11 | 2012-07-25 | Univ St Andrews | Vaccine |
| WO2014045254A2 (en) | 2012-09-23 | 2014-03-27 | Erasmus University Medical Center Rotterdam | Human betacoronavirus lineage c and identification of n-terminal dipeptidyl peptidase as its virus receptor |
| AU2013322258B2 (en) * | 2012-09-27 | 2019-06-13 | Idexx Laboratories, Inc. | Method of detection of Schmallenberg virus (SBV) and kit |
| HK1216006A1 (zh) * | 2013-03-12 | 2016-10-07 | Boehringer Ingelheim Animal Health USA Inc. | 反向遺傳學施馬倫貝格病毒疫苗組合物，和其使用方法 |
| WO2014154336A1 (en) * | 2013-03-26 | 2014-10-02 | Iffmedic Gmbh | Microtiter plate-based microarray |
| CN103472221A (zh) * | 2013-08-12 | 2013-12-25 | 南昌大学 | 荧光微球标记沙丁胺醇多克隆抗体的方法 |
| KR20230122181A (ko) | 2013-11-29 | 2023-08-22 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 중동 호흡기 증후군 코로나바이러스(MERS-CoV) 백신 |
| KR102630880B1 (ko) | 2014-03-07 | 2024-01-29 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 분석물 추출, 농축 및 검출을 통합하기 위한 장치 |
| KR102268785B1 (ko) | 2014-11-27 | 2021-06-25 | 킴벌리-클라크 월드와이드, 인크. | 표면에서 노로바이러스를 검출하기 위한 장치 및 방법 |
| CN104844710B (zh) * | 2015-04-13 | 2018-02-02 | 西北大学 | 定向固定化pega复合型树酯的制备方法及应用 |
| RU2018107453A (ru) | 2015-08-10 | 2019-09-12 | Эссенликс Корп. | Устройства для анализов и способы в биологии/химии, предусматривающие упрощенные стадии, образцы небольшого объема, повышенную скорость и простоту применения |
| WO2017041030A1 (en) | 2015-09-04 | 2017-03-09 | The Regents Of The University Of California | Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications |
| US20210011025A1 (en) | 2015-11-11 | 2021-01-14 | Serimmune Inc. | Methods and compositions for assessing antibody specificities |
| CN105368873A (zh) * | 2015-11-23 | 2016-03-02 | 艾军 | 一种表达施马伦贝格病毒重组n基因杆状病毒的制备、鉴定方法以及应用 |
| EP3184119A1 (en) * | 2015-12-23 | 2017-06-28 | Themis Bioscience GmbH | Chromatography based purification strategies for measles scaffold based viruses |
| CN105548540A (zh) * | 2015-12-29 | 2016-05-04 | 中国医学科学院医学生物学研究所 | 一种i-iv型登革热病毒的通用检测试剂盒 |
| US11648303B2 (en) | 2016-02-25 | 2023-05-16 | The Trustees Of The University Of Pennsylvania | Vaccines against zika virus |
| EP3229024A1 (de) * | 2016-04-08 | 2017-10-11 | Viramed Biotech AG | Zika virus diagnostik |
| EP4202439B1 (en) | 2016-06-09 | 2025-02-19 | The Regents of the University of California | Method of purifying and amplifying a nucleic acid |
| US11327075B2 (en) * | 2016-08-22 | 2022-05-10 | The Regents Of The University Of California | Hydrogel platform for aqueous two-phase concentration of a target to enhance its detection |
| US10012645B2 (en) * | 2016-08-24 | 2018-07-03 | The Florida International University Board Of Trustees | Rapid zika virus detection using nano-enabled electrochemical sensing system |
| US11651866B2 (en) | 2016-10-17 | 2023-05-16 | Reliant Immune Diagnostics, Inc. | System and method for real-time insurance quote in response to a self-diagnostic test |
| US11579145B2 (en) | 2016-10-17 | 2023-02-14 | Reliant Immune Diagnostics, Inc. | System and method for image analysis of medical test results |
| US11107585B2 (en) | 2016-10-17 | 2021-08-31 | Reliant Immune Diagnostics, Inc | System and method for a digital consumer medical wallet and storehouse |
| US11802868B2 (en) | 2016-10-17 | 2023-10-31 | Reliant Immune Diagnostics, Inc. | System and method for variable function mobile application for providing medical test results |
| US12009078B2 (en) | 2016-10-17 | 2024-06-11 | Reliant Immune Diagnostics, Inc. | System and method for medical escalation and intervention that is a direct result of a remote diagnostic test |
| US10902951B2 (en) | 2016-10-17 | 2021-01-26 | Reliant Immune Diagnostics, Inc. | System and method for machine learning application for providing medical test results using visual indicia |
| US9857372B1 (en) | 2016-10-17 | 2018-01-02 | Reliant Immune Diagnostics, LLC | Arbovirus indicative birth defect risk test |
| US11693002B2 (en) | 2016-10-17 | 2023-07-04 | Reliant Immune Diagnostics, Inc. | System and method for variable function mobile application for providing medical test results using visual indicia to determine medical test function type |
| WO2018148342A1 (en) | 2017-02-07 | 2018-08-16 | Essenlix Corporation | Compressed open flow assay and use |
| EP3361256A1 (en) * | 2017-02-08 | 2018-08-15 | Fundación para la Investigación Médica Aplicada | In vitro method for the diagnosis of lung cancer |
| CN108503697B (zh) * | 2017-02-27 | 2023-03-31 | 中国科学院上海巴斯德研究所 | 一种果蝇细胞表达的寨卡病毒亚单位疫苗 |
| CN107102144A (zh) * | 2017-03-16 | 2017-08-29 | 深圳市梓健生物科技有限公司 | 快速检测寨卡病毒ns1蛋白的荧光定量免疫层析试纸条及其制作方法 |
| US11209427B2 (en) | 2017-03-27 | 2021-12-28 | The Regents Of The University Of California | Semi-quantitative lateral-flow immunoassay for the detection of CSF leaks |
| JP7572780B2 (ja) * | 2017-04-26 | 2024-10-24 | エフ． ホフマン－ラ ロシュ アーゲー | 可溶性および免疫反応性のジカウイルスｎｓ１ポリペプチド |
| CN107287347B (zh) * | 2017-05-09 | 2020-12-25 | 广州机场出入境检验检疫局综合技术服务中心 | 戊型肝炎病毒实时荧光逆转录pcr检测引物、探针、检测试剂盒和检测方法 |
| RU2661085C1 (ru) * | 2017-06-01 | 2018-07-11 | Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ВБ "Вектор" Роспотребнадзора) | Рекомбинантные белки, содержащие антигенные эпитопы белков Core, Small Envelope, NS2A и preM вируса Зика, и комплексный антиген, содержащий указанные белки и используемый в качестве компонента иммуноферментной тест-системы для выявления антител классов G и M к вирусу Зика |
| WO2019039557A1 (ja) * | 2017-08-24 | 2019-02-28 | 富士レビオ株式会社 | ジカウイルスを検出する方法及びキット |
| WO2019055971A2 (en) * | 2017-09-18 | 2019-03-21 | Carrera Bioscience Inc. | MULTIPLEX ENTERIC MEASUREMENTS AND METHODS OF USE |
| JP6939535B2 (ja) * | 2017-12-27 | 2021-09-22 | トヨタ自動車株式会社 | 車両用撮影装置及び加熱装置 |
| KR102198342B1 (ko) * | 2019-05-22 | 2021-01-04 | 연세대학교 산학협력단 | 항체 선별 방법 및 이를 이용한 항체 선별 시스템 |
| US11497808B2 (en) | 2019-09-30 | 2022-11-15 | Gilead Sciences, Inc. | HBV vaccines and methods treating HBV |
| CN118787385A (zh) * | 2019-11-29 | 2024-10-18 | 重庆大学 | 胃液采样胶囊 |
| CA3172315A1 (en) * | 2020-03-20 | 2021-09-23 | Biontech Us Inc. | Coronavirus vaccines and methods of use |
| WO2021194540A1 (en) * | 2020-03-23 | 2021-09-30 | Baseline Viral Diagnostics, Inc. | Methods, systems, and a kit for detection, diagnosis, monitoring and treatment of covid-19 |
| IL297731A (en) * | 2020-04-28 | 2022-12-01 | Aviana Molecular Tech Llc | Compositions and surface acoustic wave based methods for identifying infectious disease |
| WO2021226437A1 (en) * | 2020-05-07 | 2021-11-11 | Bio-Rad Laboratories, Inc. | Sars-cov-2 immunoassay and materials therefor |
| WO2021236050A1 (en) | 2020-05-18 | 2021-11-25 | Baseline Global, Inc. | Assay device, system, method, and kit |
| US20210364530A1 (en) * | 2020-05-19 | 2021-11-25 | Aditx Therapeutics Inc. | Double-multiplex assay for multiple immunoglobulin isotypes |
| WO2021247398A1 (en) * | 2020-05-30 | 2021-12-09 | Pangolin Llc | Systems and methods to detect pathogens |
| EP4176053A4 (en) * | 2020-07-02 | 2024-12-25 | The Regents of the University of California | PERSISTENT MEMORY T CELL RESPONSES TO CANCER AND INFECTIOUS DISEASE ANTIGENS BY MANIPULATION OF AMINO ACID CATABOLIC PATHWAYS |
| EP4182687A4 (en) * | 2020-07-20 | 2024-09-11 | Bio-Rad Laboratories, Inc. | IMMUNOASSAY FOR SARS-COV-2 NEUTRALISING ANTIBODIES AND MATERIALS THEREFOR |
| US20220050105A1 (en) * | 2020-08-12 | 2022-02-17 | Boston Molecules, Inc. | Method and apparatus for detecting viruses in biological samples |
| WO2022036337A1 (en) * | 2020-08-13 | 2022-02-17 | Diaclone Llc | Compositions and methods for recombinant polypeptide mimicking sars-cov-2 nucleocapsid protein (np) |
| CN112760420B (zh) * | 2021-02-05 | 2023-05-26 | 中国科学院长春应用化学研究所 | 一种用于检测新冠病毒SARS-CoV-2的引物、探针和试剂盒 |
| WO2022241256A1 (en) * | 2021-05-13 | 2022-11-17 | Serimmune Inc. | Serum antibody profiling for leptospirosis |
| US12196755B2 (en) * | 2021-12-02 | 2025-01-14 | Zymeron Corporation | Immunoassay platform for the serological discrimination of closely related viruses |
| WO2025117490A1 (en) * | 2023-11-30 | 2025-06-05 | La Jolla Institute For Immunology | Arenavirus t cell epitopes, megapools and uses thereof |
| WO2025147586A1 (en) * | 2024-01-05 | 2025-07-10 | Agilent Technologies, Inc. | Controlling antibody specificities in a polyclonal humoral response by epitope tuning |
| CN118987257B (zh) * | 2024-08-09 | 2025-09-30 | 中国人民解放军海军军医大学第一附属医院 | 一种靶向中性粒细胞pd-l1的脂质体递药系统、其制备方法和应用 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2480764B1 (fr) | 1980-04-18 | 1985-10-04 | Rhone Poulenc Spec Chim | Latex de polymeres magnetiques et procede de preparation |
| NO155316C (no) | 1982-04-23 | 1987-03-11 | Sintef | Fremgangsmaate for fremstilling av magnetiske polymerpartikler. |
| GB2125047B (en) | 1982-08-09 | 1986-02-19 | Ciba Geigy Ag | Yeast hybrid vectors and their use for the production of polypeptides |
| WO1984001153A1 (en) | 1982-09-15 | 1984-03-29 | Collaborative Res Inc | Production of interferon in yeast by use of invertase promoter |
| WO1987002670A1 (en) | 1985-10-25 | 1987-05-07 | Mackay Vivian L | Method of using bar1 for secreting foreign proteins |
| US5879926A (en) | 1989-03-31 | 1999-03-09 | Transgene S.A. | Yeast strains for the production of mature heterologous proteins, especially hirudin |
| FR2645160B1 (enExample) | 1989-03-31 | 1992-10-02 | Rhone Poulenc Chimie | |
| JP2979414B2 (ja) | 1989-09-29 | 1999-11-15 | 富士レビオ株式会社 | 磁性粒子およびそれを用いた免疫測定法 |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| GB9224888D0 (en) * | 1992-11-27 | 1993-01-13 | Univ Singapore | Monoclonal antibody |
| DK82893D0 (da) | 1993-07-08 | 1993-07-08 | Novo Nordisk As | Peptid |
| FR2714830B1 (fr) | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
| FR2715847B1 (fr) | 1994-02-08 | 1996-04-12 | Rhone Poulenc Rorer Sa | Composition contenant des acides nucléiques, préparation et utilisations. |
| FR2727679B1 (fr) | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | Nouveaux agents de transfection et leurs applications pharmaceutiques |
| FR2730637B1 (fr) | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Composition pharmaceutique contenant des acides nucleiques, et ses utilisations |
| US5981180A (en) | 1995-10-11 | 1999-11-09 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
| WO1997014028A2 (en) | 1995-10-11 | 1997-04-17 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
| US5736330A (en) | 1995-10-11 | 1998-04-07 | Luminex Corporation | Method and compositions for flow cytometric determination of DNA sequences |
| WO1998010088A1 (en) | 1996-09-06 | 1998-03-12 | Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| US6449562B1 (en) | 1996-10-10 | 2002-09-10 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and method |
| WO1999019515A1 (en) | 1997-10-14 | 1999-04-22 | Luminex Corporation | Precision fluorescently dyed particles and methods of making and using same |
| KR100593712B1 (ko) | 1998-01-22 | 2006-06-30 | 루미넥스 코포레이션 | 다수의 형광 시그널을 갖는 마이크로입자 |
| FR2777909B1 (fr) | 1998-04-24 | 2002-08-02 | Pasteur Institut | Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex |
| ATE324588T1 (de) | 1999-08-17 | 2006-05-15 | Luminex Corp | Verkapselung von fluoreszierenden partikeln |
| EP1204869B1 (en) | 1999-08-17 | 2008-10-22 | Luminex Corporation | Method for analyzing a number of samples from a variety of sources for a single analyte |
| DE69941703D1 (de) | 1999-10-11 | 2010-01-07 | Pasteur Institut | Lentivirale Vektoren für die Herstellung von immunotherapeutischen Zusammensetzungen |
| US9709559B2 (en) * | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
| US6689615B1 (en) * | 2000-10-04 | 2004-02-10 | James Murto | Methods and devices for processing blood samples |
| NZ540410A (en) * | 2001-04-10 | 2006-06-30 | Ecole Polytech | Methods using O6-alkylguanine-DNA alkyltransferases |
| EP3252139A1 (en) * | 2001-09-06 | 2017-12-06 | Rapid Micro Biosystems, Inc. | Rapid detection of replicating cells |
| US6682507B2 (en) | 2002-02-20 | 2004-01-27 | Doug's Kangaroo Pouch, Llc | User wearable device having sterile environment for connecting peritoneal dialysis tubes |
| WO2004040263A2 (en) * | 2002-10-31 | 2004-05-13 | Health Research, Inc. | Diagnostic test for west nile virus |
| EP1501945A4 (en) * | 2002-04-30 | 2008-02-20 | Merck & Co Inc | MULTIPLEX ASSAY FOR HUMAN PAPILLOMA VIRUS |
| EP1546371A1 (en) | 2002-10-03 | 2005-06-29 | Ecole Polytechnique Federale De Lausanne (Epfl) | Substrates for o6-alkylguanine-dna alkyltransferase |
| WO2004031404A1 (en) | 2002-10-03 | 2004-04-15 | Ecole Polytechnique Federale De Lausanne (Epfl) | Protein labelling with o6-alkylguanine-dna alkyltransferase |
| EP1552307A1 (en) | 2002-10-18 | 2005-07-13 | Rescom GmbH | Diagnosis of glaucoma by complex autoantibody repertoires in body fluids |
| JP2007526282A (ja) | 2004-03-02 | 2007-09-13 | ウペエフエル・エコル・ポリテクニック・フェデラル・ドゥ・ローザンヌ | Ｏ６−アルキルグアニンｄｎａアルキルトランスフェラーゼ特異的基質 |
| CA2775655C (en) * | 2005-01-20 | 2014-03-25 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Multiplexed analysis for determining a serodiagnosis of viral infection |
| EP1920248B1 (en) * | 2005-04-05 | 2010-09-29 | Allergan, Inc. | Clostridial toxin activity assays |
| DE602006014812D1 (de) * | 2005-04-05 | 2010-07-22 | Allergan Inc | Lostridientoxinaktivität |
| JP2008539198A (ja) | 2005-04-27 | 2008-11-13 | コヴァリス・バイオサイエンシス・アーゲー | Ｏ６−アルキルグアニン−ｄｎａアルキルトランスフェラーゼと反応するピリミジン |
| EP1882688A1 (en) * | 2006-07-25 | 2008-01-30 | EPFL Ecole Polytechnique Fédérale de Lausanne | Labelling of fusion proteins with synthetic probes |
| AU2009251881B2 (en) * | 2008-03-31 | 2015-03-26 | Pacific Biosciences Of California, Inc | Single molecule loading methods and compositions |
| FR2936245B1 (fr) * | 2008-09-23 | 2012-07-06 | Cis Bio Int | Nouveaux substrats d'o6-alkylguanine-adn alkyltransferase et ses mutants. |
| CA2754980A1 (en) | 2009-03-18 | 2010-09-23 | Prometheus Laboratories Inc. | Addressable antibody arrays and methods of use |
| JP2013527752A (ja) * | 2010-03-23 | 2013-07-04 | ジンジェン バイオ カンパニー リミテッド | 融合ポリペプチドｈｐｖ抗原を用いたｈｐｖ抗体スクリーニング方法 |
| CN103476928B (zh) * | 2010-12-09 | 2017-03-29 | 巴斯德研究所 | 用于获得高产量重组蛋白表达的基于mgmt的方法 |
| EP2788478B1 (en) | 2011-12-09 | 2017-08-23 | Institut Pasteur | Multiplex immuno screening assay |
-
2012
- 2012-12-10 EP EP12798308.8A patent/EP2788478B1/en active Active
- 2012-12-10 CA CA2857998A patent/CA2857998C/en active Active
- 2012-12-10 BR BR112014013745-5A patent/BR112014013745B1/pt active IP Right Grant
- 2012-12-10 SG SG11201403010TA patent/SG11201403010TA/en unknown
- 2012-12-10 KR KR1020147018819A patent/KR102007061B1/ko not_active Expired - Fee Related
- 2012-12-10 JP JP2014545306A patent/JP6215223B2/ja active Active
- 2012-12-10 ES ES12798308.8T patent/ES2648899T3/es active Active
- 2012-12-10 US US13/883,339 patent/US9638692B2/en active Active
- 2012-12-10 NO NO12798308A patent/NO2788478T3/no unknown
- 2012-12-10 CN CN201280069229.XA patent/CN104114697A/zh active Pending
- 2012-12-10 DK DK12798308.8T patent/DK2788478T3/en active
- 2012-12-10 AU AU2012350229A patent/AU2012350229B2/en active Active
- 2012-12-10 MX MX2014006870A patent/MX349562B/es active IP Right Grant
- 2012-12-10 WO PCT/EP2012/074986 patent/WO2013083847A2/en not_active Ceased
-
2013
- 2013-05-03 MX MX2014013417A patent/MX357087B/es active IP Right Grant
- 2013-05-03 BR BR112014027465-7A patent/BR112014027465B1/pt active IP Right Grant
- 2013-05-03 NZ NZ701380A patent/NZ701380A/en not_active IP Right Cessation
- 2013-05-03 KR KR1020147031586A patent/KR102049623B1/ko active Active
- 2013-05-03 WO PCT/EP2013/059312 patent/WO2013164476A1/en not_active Ceased
- 2013-05-03 JP JP2015509458A patent/JP6351571B2/ja active Active
- 2013-05-03 CN CN201380035238.1A patent/CN104704117B/zh active Active
- 2013-05-03 EP EP13723051.2A patent/EP2844748B1/en active Active
- 2013-05-03 SG SG11201407167RA patent/SG11201407167RA/en unknown
- 2013-05-03 CA CA2872127A patent/CA2872127A1/en not_active Abandoned
- 2013-05-03 US US14/396,841 patent/US10119967B2/en active Active
- 2013-05-03 AU AU2013255744A patent/AU2013255744A1/en not_active Abandoned
-
2017
- 2017-04-06 US US15/480,451 patent/US10197562B2/en active Active
- 2017-07-19 US US15/654,272 patent/US10352930B2/en active Active
- 2017-07-19 US US15/653,949 patent/US10209248B2/en active Active